CRHBP Antikörper
Kurzübersicht für CRHBP Antikörper (ABIN7262433)
Target
Alle CRHBP Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Produktmerkmale
- Polyclonal Antibody
-
Aufreinigung
- Affinity purification
-
Immunogen
- Recombinant fusion protein of human CRHBP (NP_001873.2).
-
Isotyp
- IgG
-
-
anti-Corticotropin Releasing Hormone Binding Protein (CRHBP) (AA 25-322) antibody
CRHBP Reaktivität: Human WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Corticotropin Releasing Hormone Binding Protein (CRHBP) (AA 1-322) antibodyCRHBP Reaktivität: Human WB, IP Wirt: Kaninchen Polyclonal unconjugated
anti-Corticotropin Releasing Hormone Binding Protein (CRHBP) (AA 25-322) antibodyCRHBP Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Corticotropin Releasing Hormone Binding Protein (CRHBP) (AA 25-322) antibodyCRHBP Reaktivität: Ratte WB Wirt: Maus Monoclonal C11 unconjugated
anti-Corticotropin Releasing Hormone Binding Protein (CRHBP) (AA 1-322) antibodyCRHBP Reaktivität: Human IP, ELISA Wirt: Maus Monoclonal 3D9 unconjugated
anti-Corticotropin Releasing Hormone Binding Protein (CRHBP) (AA 7-36), (N-Term) antibodyCRHBP Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB19588 unconjugated
anti-Corticotropin Releasing Hormone Binding Protein (CRHBP) (AA 1-322) antibodyCRHBP Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
-
-
Applikationshinweise
- IHC 1:50-1:100 IF 1:50-1:100
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- CRHBP (Corticotropin Releasing Hormone Binding Protein (CRHBP))
-
Andere Bezeichnung
- CRHBP
-
Hintergrund
- Corticotropin-releasing hormone is a potent stimulator of synthesis and secretion of preopiomelanocortin-derived peptides. Although CRH concentrations in the human peripheral circulation are normally low, they increase throughout pregnancy and fall rapidly after parturition. Maternal plasma CRH probably originates from the placenta. Human plasma contains a CRH-binding protein which inactivates CRH and which may prevent inappropriate pituitary-adrenal stimulation in pregnancy.
-
Gen-ID
- 1393
-
UniProt
- P24387
-
Pathways
- Negative Regulation of Hormone Secretion
Target
-
